Spineway : Patent issued in Europe for the Mont-Blanc MIS range
04 Novembre 2019 - 8:45AM
Spineway : Patent issued in Europe for the Mont-Blanc MIS range
Press
release
Ecully, 4 November 2019
Patent issued in Europe for the
Mont-Blanc MIS range
Spineway, specialist in surgical
implants and instruments for treating disorders of the spinal
column (spine), has just been granted a new patent for its
innovative Mont-Blanc MIS range in the USA.
Since 2008, Spineway has invested in industrial
property, enabling it to display a portfolio of more than 35
patents and confirm its status as an innovative company. In line
with its strategy of strengthening its higher value-added product
lines, Spineway pursues its sustained intellectual property policy,
which results in the regular filing of new patents.
After the United States, the European Patent
Office (EPO) has just awarded Spineway a patent for its Mont-Blanc
MIS range, granting it a monopoly of exploitation and the
protection of its innovation in nearly 40 countries for a period of
20 years. This recognition confirms the innovative nature of its
MIS range, marking an important step for its redeployment.
With this patent, which strengthens the Group's
portfolio, Spineway will continue its innovation strategy and
strengthen its positions in mature countries.
SPINEWAY IS ELIGIBLE FOR THE PEA-PME
(EQUITY SAVINGS PLANS FOR SMES)
Find out all about Spineway at
www.spineway.com
This press release has been prepared in both
English and French. In case of discrepancies, the French version
shall prevail.
Spineway
designs, manufactures and markets innovative implants and surgical
instruments for treating severe disorders of the spinal
column.Spineway has an international network of
over 50 independent distributors and 90% of its revenue comes from
exports.Spineway, which is eligible for investment
through FCPIs (French unit trusts specializing in innovation), has
received the OSEO Excellence award since 2011 and has won the
Deloitte Fast 50 award (2011). Rhône Alpes INPI Patent Innovation
award (2013) – INPI Talent award (2015). ISIN:
FR0011398874 - ALSPW
Contacts:
Spineway Shareholder-services
lineAvailable Tuesday through Thursday (10 a.m. – 12
p.m.)+33 (0)811 045 555 |
|
AeliumFinance et Communication Investor
relationsSolène Kennisspineway@aelium.fr |
- SPW_CP_Brevet_MB_MIS_Europe_GB_VD
Spineway (EU:ALSPW)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Spineway (EU:ALSPW)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024